Determinants of the Clinical Course of Infection

About this project

The identification of these antibodies has also led to the development of novel diagnostic techniques for the virus in patient samples (HEV antigen, IgG-ELISA). Alongside other serological and functional analyses (neutralization experiments), we are actively engaged in the identification of factors influencing the clinical course of infection and markers for guiding the therapeutic use of ribavirin in chronically infected patients.